The invention relates to an extended release formulation comprising hard gelatin capsule containing a therapeutically effective amount of mini-tablets comprised of venlafaxine hydrochloride, binder, diluent and coating comprising of water soluble polymer and water insoluble component which reseases the venlafaxine hydrochloride in a predetermined manner. The diameter of mini-tablet ranges etween 3-6mm.